Metabolic syndrome: Frequency of its components and global risk for coronary heart disease;Síndrome metabólico: Frecuencia de sus componentes y riesgo global de cardiopatía coronaria

Acta Bioquimica Clinica Latinoamericana

Volumn 45, Issue 3, 2011, Pages 413-421

  Coniglio, Raúl Ignacio ^a,c,d   Nellem, Jorge ^b,c   Sibechi, Norberto ^a,c   Colombo, Osvaldo ^b,e  

^a Bioquímica UBA   (Argentina)

^b Bioquímico ^*  (Argentina)

^c Fundación de la Asociación de Laboratorios de Alta Complejidad ALAC   (Argentina)

^d Instituto Bioquímico Clínico Integral SRL   (Argentina)

^e Sanatorio Austral SRL   (Argentina)

Author keywords

Frequency of components; Global risk for coronary heart disease (Framingham Study); Metabolic syndrome

Indexed keywords

EID: 84856643917     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Ross R. Atherosclerosis - An inflammatory disease. New Engl J Med 1999;340:115-26. (Pubitemid 29054847)
2. Sosa Liprandi MI, González MA, Rivero Ayerza MR, Iglesias RM, Vilar de Sarachaga D, Sosa Liprandi A. Ten-dencias de la mortalidad por infarto agudo de miocardio en la República Argentina durante el período 1980-1997. Rev Argent Cardiol 1999;67:733-8.
3. Davidson JA, Moreno PR, Badimon JJ, Lopez-Candales A, Maisonet Giachello AL, Ovalle F, et al. Cardiovascular disease prevention and care in Latino and Hispanic subjects. Endocrinol Pract 2007;13:77-85.
4. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation 2002;106:3143-421.
5. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti L, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. (Pubitemid 32893993)
6. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Jose R, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50. (Pubitemid 39202340)
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1988;15:539-53.
8. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.
9. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American Collage of Endocrinology position statement on the insulin resistance syndrome. Endocrinol Pract 2003;9:237-52.
10. Alberti KG, Zimmet P, Shaw J, and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
12. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome. Circulation 2009;120:1640-5.
13. Coniglio RI, Nellem J, Gentili R, Sibechi N, Agusti E, Torres M, et al, por los autores del Estudio Ifralac 0001. Síndrome metabólico en empleados en la Argentina. Medicina (Buenos Aires) 2009;69:246-52.
14. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino Sr RB, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007;30:1219-25. (Pubitemid 46684651)
15. Grundy SM. Atherogenic dyslipemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006;8 Suppl 1:S21-7. (Pubitemid 44283558)
16. Hoang KC, Ghandehari H, Lopez VA, Barboza MG, Wong ND. Global coronary heart disease risk assessment of US persons with the metabolic syndrome. Diabetes Care 2008;31:1405-9.
17. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
18. Flegal KM, Carroll MD, Orden CL, Jonson CL. Prevalence and treds in obesity among US adults 1999-2000. JAMA 2002;288:1723-7.
19. Montani J-P, Antic V, Zang Z, Dulloo A. Pathways from obesity to hypertension: from the perspectiva of a vicious triangle. Intern J Obes 2002;26:S28-38. (Pubitemid 35034485)
20. Jonk AM, Houben AJ, Jongh RT de, Serne EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potencial mechanism in the pathogenesis of obesityassociated insulin resistance and hypertension. Physiology 2007;22:252-60.
21. Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes and vascular diseases. Eur Heart J 2008;29:2959-71.
22. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9. (Pubitemid 29504045)
23. Reaven G. Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106:286-8. (Pubitemid 34778947)
24. Li C, Ford ES, Meng YX, Reaven GM. Does the association of the triglyceride to high density lipoprotein cholesterol ratio with fasting serum insulin differ by race ethnicity? Cardiovasc Diabetol 2008;7:4.
25. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006;29:1689-92. (Pubitemid 44127605)
26. Reaven G. Just being alive is not good enough. Clin Chem 2005;51:1354-7 (Pubitemid 41060866)
27. Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K, et al. Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 2007;30:343-7. (Pubitemid 46198341)
28. Reaven G. Why a cluster is truly a cluster: Insulin resistance and cardiovascular disease. Clin Chem 2008;54:785-7. (Pubitemid 351671594)
29. Reaven G. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
30. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004;24:e13-18.
31. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004;21:52-8. (Pubitemid 38168029)
32. Eckel RH. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Proc Nutr Soc 2007;66:82-95. (Pubitemid 46748247)
33. Hsu PF, Chiang SY, Chen HM, Tsai ST, Chou P, Chen CH. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study. Diabetes Res Clin Pract 2008;79:461-7. (Pubitemid 351273451)
34. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
35. Goff DC, Nichman MZ, Chan W, Ramsey DJ, Labarthe DR, Ortiz C. Greater incident of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites: The Corpus Christi Heart Project 1988-1992. Circulation 1997;95:1433-40. (Pubitemid 27142800)
36. Akosah KO, McHugh VL, Mathiasson MA, Kulkarni A, Barnhart SI. Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults. J Cardiometab Syndr 2006;1:173-7.
37. Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, Touboul PJ et al. CARMELA: assessment of cardiovascular risk in seven Latin American Cities. Am J Med 2008;121:58-65.
38. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, et al. Framingham risk equation understimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006;184:201-6. (Pubitemid 41721089)